Human lung lavage surfactant enhances staphylococcal phagocytosis by alveolar macrophages

Area of Science:

• Pulmonary immunology
• Innate immunity
• Microbiology

Background:

• Alveolar macrophages (AM) are crucial for lung defense against bacterial pathogens.
• Phagocytosis and intracellular killing are key mechanisms by which AM combat infections like Staphylococcus aureus.
• The role of pulmonary surfactant in modulating AM function requires further elucidation.

Purpose of the Study:

• To investigate the effect of surfactant-associated material (SAM) on the phagocytic capacity of human AM.
• To determine SAM's impact on the intracellular killing of Staphylococcus aureus by human AM.
• To assess SAM's potential as a non-immune opsonin for AM.

Main Methods:

• Human alveolar macrophages (AM) were incubated with Staphylococcus aureus in the presence of varying concentrations of human lung lavage surfactant (SAM).
• Phagocytosis was quantified by measuring intracellular bacterial counts per AM.
• Intracellular killing efficiency was assessed by comparing initial phagocytosis levels with the remaining bacterial load over time.

Main Results:

• Incubation with SAM (100-300 µg) significantly enhanced the phagocytosis of Staphylococcus aureus by human AM (p < 0.001).
• Mean intracellular staphylococci per AM were 36.0 ± 2.7 in the SAM group versus 23.3 ± 2.8 in the control group.
• SAM did not significantly improve the intracellular killing efficiency of Staphylococcus aureus by AM (p > 0.05).

Conclusions:

• Surfactant-associated material (SAM) acts as a non-immune opsonin, promoting bacterial phagocytosis by human alveolar macrophages.
• SAM enhances the uptake of Staphylococcus aureus but does not augment the intracellular killing capabilities of AM.
• These findings highlight SAM's role in innate immune responses within the lung.